An HIV/AIDS vaccine developed by University of Western Ontario professor Chil-Yong Kang has reached "an important milestone" as it pushes towards the first phase of human trials. More
A flavonoid derived from citrus fruit has shown tremendous promise for preventing weight gain and other signs of metabolic syndrome which can lead to Type 2 Diabetes and increased risk of cardiovascular disease. More
Pisa -- May, 2006 30th Abiogen Pharma today announced the start of a Phase II clinical trial in Vienna (Austria) in patients affected by GAD with ABIO 08/01, a new anti-anxiety drug. More
The eighth BioBusiness Asia conference, a two-day gathering of life science business professionals from around Asia held annually in Taipei, Taiwan, opened its doors today. More
London Health Sciences Centre (LHSC) and Lawson Health Research Institute
(Lawson) are pleased to announce a Canadian first in the treatment of lung
cancer. On May 13, 2009 surgeon and clinical researcher Dr. Richard Malthaner and oncologist Dr. Edward More
Western virologist Yong Kang's research now at toxicology testing stage, with phase 1 human clinical trials to begin as early as three months from now. More
"MENOPUR(tm) is at least as effective and well tolerated as genetically-engineered, so called recombinant FSH in women undergoing in-vitro fertilisation treatment" More
Displaying 1..10 of 558 -
per page
Next page
Order by
All rights reserved. Terms and Conditions | Contact us
